Trade-Ideas LLC identified

PerkinElmer

(

PKI

) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified PerkinElmer as such a stock due to the following factors:

  • PKI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $28.6 million.
  • PKI has traded 75.0597000000000065256244852207601070404052734375 options contracts today.
  • PKI is making at least a new 3-day high.
  • PKI has a PE ratio of 35.
  • PKI is mentioned 0.94 times per day on StockTwits.
  • PKI has not yet been mentioned on StockTwits today.
  • PKI is currently in the upper 20% of its 1-year range.
  • PKI is in the upper 35% of its 20-day range.
  • PKI is in the upper 45% of its 5-day range.
  • PKI is currently trading above yesterday's high.

TST Recommends

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PKI with the Ticky from Trade-Ideas. See the FREE profile for PKI NOW at Trade-Ideas

More details on PKI:

PerkinElmer Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The stock currently has a dividend yield of 0.6%. PKI has a PE ratio of 35. Currently there are 12 analysts that rate PerkinElmer a buy, no analysts rate it a sell, and 4 rate it a hold.

The average volume for PerkinElmer has been 704,400 shares per day over the past 30 days. PerkinElmer has a market cap of $5.7 billion and is part of the health care sector and health services industry. The stock has a beta of 0.38 and a short float of 3.2% with 5.68 days to cover. Shares are up 17% year-to-date as of the close of trading on Thursday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates PerkinElmer as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from the ratings report include:

  • PKI's revenue growth has slightly outpaced the industry average of 8.0%. Since the same quarter one year prior, revenues slightly increased by 1.3%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • The current debt-to-equity ratio, 0.47, is low and is below the industry average, implying that there has been successful management of debt levels. Along with the favorable debt-to-equity ratio, the company maintains an adequate quick ratio of 1.08, which illustrates the ability to avoid short-term cash problems.
  • Net operating cash flow has increased to $63.47 million or 16.68% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of 0.96%.
  • The gross profit margin for PERKINELMER INC is rather high; currently it is at 50.10%. It has increased from the same quarter the previous year. Regardless of the strong results of the gross profit margin, the net profit margin of 8.68% trails the industry average.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.